Get started
Author

Emily Clayton

Observed names: Clayton, Emily, E Clayton, E. Clayton
ORCID: 0000-0002-6840-1105
Observed ORCID: 0000-0002-6840-1105
OpenAlex ID: A5059633855
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
2019 · Shelley Potter, Elizabeth J Conroy, et al. · The Lancet Oncology · 211
PDF
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan
2022 · Andrea Leith, Amanda Ribbands, et al. · BMC Urology · 54
PDF
Fundamental Characteristics of Bat Interferon Systems
2020 · Emily Clayton, Muhammad Munir · Frontiers in Cellular and Infection Microbiology · 45
PDF
Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan
2022 · Andrea Leith, Jeri Kim, et al. · Advances in Therapy · 39
PDF
Reasons for oncologist and urologist treatment choice in metastatic castration-sensitive prostate cancer (mCSPC): A physician survey linked to patient chart reviews in the United States.
2022 · Stephen J. Freedland, Zachary William Abraham Klaassen, et al. · Journal of Clinical Oncology · 15
Real-world health-related quality of life and caregiver need in patients with metastatic hormone-sensitive and metastatic castration-resistant prostate cancer.
2022 · Mark Boye, Amanda Ribbands, et al. · Journal of Clinical Oncology · 10
The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2
2021 · Emily Clayton, Mohammed A. Rohaim, et al. · Advances in experimental medicine and biology · 9
Interferon-induced protein with tetratricopeptide repeats 5 of black fruit bat (Pteropus alecto) displays a broad inhibition of RNA viruses
2024 · Emily Clayton, Mustafa O. Atasoy, et al. · Frontiers in Immunology · 8
PDF
Op0190 Understanding Current Prescription Drug Treatment Paradigms for Patients With Osteoarthritis in Europe
2020 · P.G. Conaghan, L. Abraham, et al. · Annals of the Rheumatic Diseases · 3
PDF
Fri0396 How Does Osteoarthritis Pain Impact Function, Mobility and Requirement for Help in Daily Activities in European Patients?
2020 · P.G. Conaghan, L. Abraham, et al. · Annals of the Rheumatic Diseases · 2
PDF
Abstract PS7-59: Presence of comorbidities and use of concomitant medications associated with QTC prolongation/torsades de pointes in patients with HR+/HER2- advanced breast cancer
2021 · Reshma Mahtani, Katie Lewis, et al. · Cancer Research · 1
239P Impact of clinical characteristics, patients' perception of treatment goals and endocrine therapy history on HRQOL in HR+, HER2- early stage breast cancer patients
2020 · R. Williams, J. Brown, et al. · Annals of Oncology · 1
PDF
240P A multinational real-world study on HR+, HER2- early stage breast cancer patients' disease awareness, satisfaction, and involvement in treatment decisions
2020 · A. Rider, M. Method, et al. · Annals of Oncology · 1
Fri0397 the Impact of Osteoarthritis Disease Severity on Healthcare Resource Use: Analysis of Real-world European Data
2020 · P.G. Conaghan, L. Abraham, et al. · Annals of the Rheumatic Diseases · 1
PDF
634P Real-world (RW) health-related quality of life (QoL) in patients (pts) with follicular lymphoma (FL): Comparisons by line of therapy (LOT) and region (Europe vs United States (US))
2022 · P.C. Johnson, A.L. Bailey, et al. · Annals of Oncology
PDF
P1095: Treatment Attributes for 3rd Line Follicular Lymphoma Treatment Decision-making: Physician Perspectives From a Survey Across Western Europe and the United States
2022 · P. C. Johnson, A. Bailey, et al. · HemaSphere
305P Real-world health-related quality of life (HRQoL) among HER2-negative (HER2-) advanced breast cancer (ABC) patients in EU3 and US
2021 · K. Lewis, K. Ndirangu, et al. · Annals of Oncology
306P Real-world study of treatments received and treatment satisfaction among HER2- advanced breast cancer (ABC) patients in EU3 and US
2021 · K. Lewis, I. Chabot, et al. · Annals of Oncology
PDF
Works count: 21
Citation count: 400
H-index: 8
I10-index: 6
Year
Topic
Type